OverviewChartNewsTraderScreen

TELA Bio/  US8723811084  /

IEX
2024-04-26  9:59:45 PM Chg. +0.06 Volume Bid- Ask- High Low
4.45USD +1.37% 1,327
Turnover: 5,897.80		 -Bid Size: - -Ask Size: - 4.58 4.42
GlobeNewswire 04-25 TELA Bio to Announce First Quarter 2024 Financial Results
GlobeNewswire 04-15 TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need fo...
GlobeNewswire 04-08 TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
GlobeNewswire 03-21 TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial R...
GlobeNewswire 03-21 TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for I...
GlobeNewswire 03-20 MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing
GlobeNewswire 03-20 TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX
GlobeNewswire 02-29 TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 02-23 TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 01-19 TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2023-12-15 TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2023-12-05 TELA Bio to Take Part in Connecting the Dots
GlobeNewswire 2023-11-16 TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference
GlobeNewswire 2023-11-10 TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2023-11-09 TELA Bio Reports Third Quarter 2023 Financial Results
GlobeNewswire 2023-10-26 TELA Bio to Announce Third Quarter 2023 Financial Results
GlobeNewswire 2023-09-18 TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase
GlobeNewswire 2023-08-16 TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Recons...
GlobeNewswire 2022-03-21 TELA Bio Reports Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire 2022-03-16 TELA Bio to Participate in Upcoming Canaccord Genuity Musculoskeletal Conference in Chicago, IL
GlobeNewswire 2022-03-07 TELA Bio to Announce Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire 2022-03-03 TELA Bio Announces U.S. Commercial Launch of SiteGuard™ No Rinse Antimicrobial Solution
GlobeNewswire 2022-02-25 TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2021-11-16 Artios Appoints Nora Brennan to Board of Directors and Audit Committee Chair
GlobeNewswire 2021-11-10 TELA Bio Reports Strong Third Quarter 2021 Revenues Reflecting Continued Growth Driven by Increased ...